HF
CRDF icon

HRT Financial’s Cardiff Oncology CRDF Stock Holding History

HRT Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+272,786
New +$433K ﹤0.01% 2958
2026
Q1 		– Sell
-29,408
Closed -$82K – 3929
2025
Q4 		$82K Buy
29,408
+15,073
+105% +$35K ﹤0.01% 2812
2025
Q3 		$29K Buy
+14,335
New +$39.6K ﹤0.01% 2661
2024
Q2 		– Sell
-67,889
Closed -$362K – 2348
2024
Q1 		$362K Buy
+67,889
New +$180K ﹤0.01% 1443
2021
Q2 		– Sell
-283,885
Closed -$2.63M – 2949
2021
Q1 		$2.63M Buy
+283,885
New +$3.45M 0.03% 482

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial's CRDF Position: Q2 2026 in Review

HRT Financial opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 272,786 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #2958 among its holdings. This is a return to the name: HRT Financial previously reported a position in CRDF as recently as Q4 2025.

HRT Financial first reported a position in CRDF in Q1 2021 and has held it in 5 quarters since. The position peaked at $2.63M in Q1 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • HRT Financial held 272,786 shares of Cardiff Oncology worth $354K as of Q2 2026.
  • Cardiff Oncology was a new HRT Financial position in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2958 holding.
  • HRT Financial first reported a position in Cardiff Oncology in Q1 2021 and has held it in 5 quarters since.
  • HRT Financial's Cardiff Oncology position peaked at $2.63M in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.